Literature DB >> 20412806

Mechanisms involved in the enhancement of mammalian target of rapamycin signalling and hypertrophy in skeletal muscle of myostatin-deficient mice.

Christopher Lipina1, Hannah Kendall, Alexandra C McPherron, Peter M Taylor, Harinder S Hundal.   

Abstract

Myostatin deficiency leads to both an increased rate of protein synthesis and skeletal muscle hypertrophy. However, the mechanisms involved in mediating these effects are not yet fully understood. Here, we demonstrate that genetic loss of myostatin leads to enhanced muscle expression of both protein kinase B and mammalian target of rapamycin/S6K signalling components, consistent with their elevated activity. This is associated with a reduction in the expression of PGC1alpha and COX IV, proteins which play important roles in maintaining mitochondrial function. Furthermore, we show that these changes in signalling and protein expression are largely independent of alterations in intramuscular amino acid content. Our findings, therefore, reveal potential new mechanisms and further contribute to our understanding of myostatin-regulated skeletal muscle growth and function. Copyright 2010 Federation of European Biochemical Societies. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20412806      PMCID: PMC2874630          DOI: 10.1016/j.febslet.2010.04.039

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  63 in total

1.  Myostatin induces cachexia by activating the ubiquitin proteolytic system through an NF-kappaB-independent, FoxO1-dependent mechanism.

Authors:  Craig McFarlane; Erin Plummer; Mark Thomas; Alex Hennebry; Murray Ashby; Nicholas Ling; Heather Smith; Mridula Sharma; Ravi Kambadur
Journal:  J Cell Physiol       Date:  2006-11       Impact factor: 6.384

Review 2.  Therapeutic approaches for muscle wasting disorders.

Authors:  Gordon S Lynch; Jonathan D Schertzer; James G Ryall
Journal:  Pharmacol Ther       Date:  2006-12-08       Impact factor: 12.310

3.  Insulin signalling to mTOR mediated by the Akt/PKB substrate PRAS40.

Authors:  Emilie Vander Haar; Seong-Il Lee; Sricharan Bandhakavi; Timothy J Griffin; Do-Hyung Kim
Journal:  Nat Cell Biol       Date:  2007-02-04       Impact factor: 28.824

4.  Myostatin gene deletion prevents glucocorticoid-induced muscle atrophy.

Authors:  H Gilson; O Schakman; L Combaret; P Lause; L Grobet; D Attaix; J M Ketelslegers; J P Thissen
Journal:  Endocrinology       Date:  2006-10-12       Impact factor: 4.736

Review 5.  Muscle cachexia: current concepts of intracellular mechanisms and molecular regulation.

Authors:  P O Hasselgren; J E Fischer
Journal:  Ann Surg       Date:  2001-01       Impact factor: 12.969

6.  Transcriptional profiling of myostatin-knockout mice implicates Wnt signaling in postnatal skeletal muscle growth and hypertrophy.

Authors:  Carissa A Steelman; Justin C Recknor; Dan Nettleton; James M Reecy
Journal:  FASEB J       Date:  2006-01-19       Impact factor: 5.191

7.  Extracellular signal-regulated kinase 1/2 mitogen-activated protein kinase pathway is involved in myostatin-regulated differentiation repression.

Authors:  Wei Yang; Yan Chen; Yong Zhang; Xueyan Wang; Ning Yang; Dahai Zhu
Journal:  Cancer Res       Date:  2006-02-01       Impact factor: 12.701

8.  Hypoglycemic effect of isoleucine involves increased muscle glucose uptake and whole body glucose oxidation and decreased hepatic gluconeogenesis.

Authors:  Masako Doi; Ippei Yamaoka; Mitsuo Nakayama; Kunio Sugahara; Fumiaki Yoshizawa
Journal:  Am J Physiol Endocrinol Metab       Date:  2007-02-13       Impact factor: 4.310

9.  Sprinting without myostatin: a genetic determinant of athletic prowess.

Authors:  Se-Jin Lee
Journal:  Trends Genet       Date:  2007-09-19       Impact factor: 11.639

10.  Loss of myostatin expression alters fiber-type distribution and expression of myosin heavy chain isoforms in slow- and fast-type skeletal muscle.

Authors:  Stefan Girgenrath; Kening Song; Lisa-Anne Whittemore
Journal:  Muscle Nerve       Date:  2005-01       Impact factor: 3.217

View more
  27 in total

1.  Maternal low-protein diet affects myostatin signaling and protein synthesis in skeletal muscle of offspring piglets at weaning stage.

Authors:  Xiujuan Liu; Shifeng Pan; Xiao Li; Qinwei Sun; Xiaojing Yang; Ruqian Zhao
Journal:  Eur J Nutr       Date:  2014-09-30       Impact factor: 5.614

2.  Myostatin inhibition induces muscle fibre hypertrophy prior to satellite cell activation.

Authors:  Qian Wang; Alexandra C McPherron
Journal:  J Physiol       Date:  2012-03-05       Impact factor: 5.182

3.  Inhibition of FoxO transcriptional activity prevents muscle fiber atrophy during cachexia and induces hypertrophy.

Authors:  Sarah A Reed; Pooja B Sandesara; Sarah M Senf; Andrew R Judge
Journal:  FASEB J       Date:  2011-11-18       Impact factor: 5.191

4.  Smad3 induces atrogin-1, inhibits mTOR and protein synthesis, and promotes muscle atrophy in vivo.

Authors:  Craig A Goodman; Rachel M McNally; F Michael Hoffmann; Troy A Hornberger
Journal:  Mol Endocrinol       Date:  2013-09-03

5.  Effect of postdevelopmental myostatin depletion on myofibrillar protein metabolism.

Authors:  Stephen Welle; Sangeeta Mehta; Kerri Burgess
Journal:  Am J Physiol Endocrinol Metab       Date:  2011-03-15       Impact factor: 4.310

Review 6.  Malnutrition in cirrhosis: contribution and consequences of sarcopenia on metabolic and clinical responses.

Authors:  Pranav Periyalwar; Srinivasan Dasarathy
Journal:  Clin Liver Dis       Date:  2012-01-23       Impact factor: 6.126

7.  Association of the K153R polymorphism in the myostatin gene and extreme longevity.

Authors:  Nuria Garatachea; Tomàs Pinós; Yolanda Cámara; Gabriel Rodríguez-Romo; Enzo Emanuele; Giovanni Ricevuti; Letizia Venturini; Alejandro Santos-Lozano; Catalina Santiago-Dorrego; Carmen Fiuza-Luces; Thomas Yvert; Antoni L Andreu; Alejandro Lucia
Journal:  Age (Dordr)       Date:  2013-01-25

8.  Role of IGF-I in follistatin-induced skeletal muscle hypertrophy.

Authors:  Caroline Barbé; Stéphanie Kalista; Audrey Loumaye; Olli Ritvos; Pascale Lause; Benjamin Ferracin; Jean-Paul Thissen
Journal:  Am J Physiol Endocrinol Metab       Date:  2015-07-28       Impact factor: 4.310

Review 9.  Myostatin and the skeletal muscle atrophy and hypertrophy signaling pathways.

Authors:  J Rodriguez; B Vernus; I Chelh; I Cassar-Malek; J C Gabillard; A Hadj Sassi; I Seiliez; B Picard; A Bonnieu
Journal:  Cell Mol Life Sci       Date:  2014-07-31       Impact factor: 9.261

10.  The methyltransferase SMYD3 mediates the recruitment of transcriptional cofactors at the myostatin and c-Met genes and regulates skeletal muscle atrophy.

Authors:  Valentina Proserpio; Raffaella Fittipaldi; James G Ryall; Vittorio Sartorelli; Giuseppina Caretti
Journal:  Genes Dev       Date:  2013-06-01       Impact factor: 11.361

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.